MedPage Today on MSN
GLP-1 Drugs May Benefit Cancer Patients With Brain Lesions
Retrospective study finds link between blockbuster drugs and longer survival ...
The evolving story of GLP-1 receptor agonists in oncology has yet another new chapter.Several studies presented at San Antonio Breast Cancer Symposium suggested the medications may help extend ...
Simple 'cocktail' of amino acids dramatically boosts power of mRNA therapies and CRISPR gene editing
Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution. Researchers ...
Epcoritamab plus R-DHAX/C achieved 79% ORR and 69% CR, with median 1.4 months to response and early activity evident by the first week-6 assessment. Over half of patients reached ASCT after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results